AbInitio Bio
The Intelligence layer for Drug Manufacturing
About AbInitio Bio
Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
Public traction evidence
Each signal links to the public source used for attribution.
- LinkedIn
Just wrapped Y Combinator P26 with Daniel Mukasa, PhD for Abinitio Bio!
Just wrapped Y Combinator P26 with Daniel Mukasa, PhD for Abinitio Bio! The founder names Abinitio Bio, cofounder Daniel Mukasa, and Y Combinator P26 in the native post. Visible metrics: 137 likes, 137 reactions, 7 comments.
- LinkedIn
I'm excited to officially share my recent career move with my network!
I'm excited to officially share my recent career move with my network! I just wrapped up two incredible years at Broad Institute of MIT and Harvard in the lab of Pardis Sabeti as a scientist, doing end-to-end pathogen surveillance in West Africa. This experience has blown up my...
- X
Excited for this next step! Reach out for more info Quote Y Combinator @ycombinator · May 22 Abinitio Bio is building the foundation models for biomanufacturing, turning 6-18 month process decisions into hours of compute and saving pharma $100M+ per month of delay on blockbusters. Congrats on the launch, @DanielMukasa1! https:// ycombinator.com/launches/QS3-a binitio-bio-frontier-foundation-models-for-biomanufacturing …
Excited for this next step! Reach out for more info Quote Y Combinator @ycombinator · May 22 Abinitio Bio is building the foundation models for biomanufacturing, turning 6-18 month process decisions into hours of compute and saving pharma $100M+ per month of delay on...
- X
An incredible team behind this, a must watch for tomorrow!
An incredible team behind this, a must watch for tomorrow!